Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 17,214 | 9,646 | 17,340 | 15,590 | 60,410 |
| Depreciation Amortization | 4,495 | 3,590 | 2,830 | 2,590 | 2,810 |
| Accounts receivable | -729 | -7,032 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 624 | 3,255 | N/A | N/A | N/A |
| Other Working Capital | -4,592 | -11,035 | -3,410 | -1,160 | 1,840 |
| Other Operating Activity | -953 | 10,933 | 3,200 | 3,430 | -41,990 |
| Operating Cash Flow | $16,059 | $9,357 | $19,960 | $20,450 | $23,070 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,270 | -4,489 | -2,660 | -2,430 | -2,760 |
| Net Acquisitions | N/A | -38,017 | 5,330 | -2,140 | 59,650 |
| Purchase Sale Intangibles | -19,486 | -18,687 | N/A | N/A | N/A |
| Other Investing Activity | -19,486 | -18,687 | -12,630 | 4,440 | -10 |
| Investing Cash Flow | $-27,756 | $-61,193 | $-9,960 | $-130 | $56,880 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,642 | 3,662 | N/A | N/A | N/A |
| Dividend Paid | -5,029 | -4,373 | -3,220 | -2,140 | 0 |
| Other Financing Activity | -40 | -87 | -2,970 | -5,100 | -27,980 |
| Financing Cash Flow | $-1,427 | $-798 | $-6,190 | $-7,240 | $-27,980 |
| Exchange Rate Effect | -91 | 4 | 50 | 4 | -50 |
| Beginning Cash Position | 22,317 | 74,947 | 71,080 | 58,000 | 6,070 |
| End Cash Position | 9,102 | 22,317 | 74,940 | 71,080 | 58,000 |
| Net Cash Flow | $-13,215 | $-52,630 | $3,860 | $13,080 | $51,920 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,059 | 9,357 | 19,960 | 20,450 | 23,070 |
| Capital Expenditure | -8,270 | -4,489 | N/A | N/A | N/A |
| Free Cash Flow | 7,789 | 4,868 | 19,960 | 20,450 | 23,070 |